Last reviewed · How we verify

NCT05765968

Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders

Status unknown NA Last updated 14 March 2023
What this trial tests

NA trial testing Double Stimulation Protocol in Infertility in 1,198 participants. Status unknown.

Timeline
14 March 2023
Primary endpoint
1 March 2026
1 April 2026

Quick facts

Lead sponsorShandong University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment1,198
Start date14 March 2023
Primary completion1 March 2026
Estimated completion1 April 2026
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Shandong University

Who can join

20 and older, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the difference in cumulative live birth rates within one year between double stimulations protocol and two-cycle antagonist protocol in poor ovarian responders.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Shandong University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05765968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing